VivaLNK Partners with Emory University to Provide Wearable ECG Sensors for Study

VivaLNK, a Campbell, CA-based connected healthcare solutions provider, teamed up with....

Image: VivaLNK

VivaLNK, a Campbell, CA-based connected healthcare solutions provider, teamed up with Emory University to provide its medical wearable ECG sensors for a study to evaluate autonomic function in predicting coronary artery disease (CAD) and its relationship to depression and long-term outcomes. The study builds upon previous work by Emory researchers titled Circadian Autonomic Inflexibility: A Marker of Ischemic Heart Disease, which associates lower heart rate variability (HRV) with subclinical myocardial ischemia.

Read more VivaLNK Offers its Wearable Healthcare Devices to Stanford University for Study on Stress and Teenage Depression

The VivaLNK ECG patch contains a sensor and accelerometer to capture and generate multiple physiological data including ECG trace, heart rate, RR-interval, and 3-axis motion. About the size of a small bandage, the reusable and rechargeable patch weighs a mere 7.5 grams, and can be worn continuously for 72 hours at-a-time to capture and transmit data in real time, the company said in a press release.

“VivaLNK's ECG patch is very small and comfortable to wear, which are important factors for clinical use and long-term ECG monitoring,” said Amit Shah, MD, Assistant Professor of Epidemiology at the Rollins School of Public Health at Emory University. “In addition, the software development kit makes it easy to use the patch for research and product development purposes.”

Image: Emory University

The researchers will use the device to remotely monitor patients who are undergoing coronary angiography, in order to measure autonomic function. Participants will be monitored using the ECG patch for continuous 72-hour periods in a clinical and ambulatory environment, which offers a more complete picture in a natural setting.

Read more Apple Joins Eli Lilly to Study How iPhone and Apple Watch Can Detect Signs of Dementia

The goal is to better understand the role of the autonomic nervous system in depression and coronary artery disease, and to develop better tools for clinical assessment.

VivaLNK provides connected healthcare solutions for wellness, patient care, and telemedicine. The company's portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals.

Sam Draper
September 10, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

ams Introduces AS6221, A Digital Temperature Sensor, Delivering Accurate Data for Wearables

ams announced the launch of the AS6221, a digital temperature sensor, which the company claims to...

Myia Labs Raises $10 Million in Series A Funding Led by Mercy Virtual

AI health firm Myia Labs has raised $10 million in a Series A funding for...

iMorph Launching Wearable Technology Solution for Smoking Cessation Clinical Trial

iMorph readies prototype CigFree SmartBand, a low-cost all-natural non-invasive solution.

Korean Scientists Develop Stretchable and Printable Free-Form Lithium-Ion Batteries

Soft, mechanically deformable, and stretchable lithium battery for development of wearable devices.
Discover more